Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Strati

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Cell|January 20, 2022
Magnesium sensing via LFA-1 regulates CD8<sup>+</sup> T cell effector functionJonas Lötscher, Adrià-Arnau Martí I Líndez, Nicole Kirchhammer, et al.
Blood Advances|February 26, 2026
Real-World Outcomes and Toxicities of CAR-T in Relapsed/Refractory Follicular Lymphoma: A Multicenter Cohort StudyJohn Sharp, Paolo Strati, Subodh Bhatta, et al.
Blood Advances|August 22, 2020
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphomaPaolo Strati, Loretta J Nastoupil, Jason Westin, et al.
Blood Advances|July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicityUri Greenbaum, Paolo Strati, Rima M Saliba, et al.
Blood Cancer Discovery|June 10, 2022
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II ExpressionGuangchun Han, Qing Deng, Mario L Marques-Piubelli, et al.
Blood Cancer Discovery|May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell LymphomaNeeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Blood|February 12, 2025
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphomaLaura Samples, Hossein Sadrzadeh, Matthew J Frigault, et al.
Nature Medicine|March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.
Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Cell|January 20, 2022
Magnesium sensing via LFA-1 regulates CD8<sup>+</sup> T cell effector functionJonas Lötscher, Adrià-Arnau Martí I Líndez, Nicole Kirchhammer, et al.
Blood Advances|February 26, 2026
Real-World Outcomes and Toxicities of CAR-T in Relapsed/Refractory Follicular Lymphoma: A Multicenter Cohort StudyJohn Sharp, Paolo Strati, Subodh Bhatta, et al.
Blood Advances|August 22, 2020
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphomaPaolo Strati, Loretta J Nastoupil, Jason Westin, et al.
Blood Advances|July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicityUri Greenbaum, Paolo Strati, Rima M Saliba, et al.
Blood Cancer Discovery|June 10, 2022
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II ExpressionGuangchun Han, Qing Deng, Mario L Marques-Piubelli, et al.
Blood Cancer Discovery|May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell LymphomaNeeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Blood|February 12, 2025
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphomaLaura Samples, Hossein Sadrzadeh, Matthew J Frigault, et al.
Nature Medicine|March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.
Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.
Pageof 14